{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:15:27Z","timestamp":1779290127903,"version":"3.51.4"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1093\/rheumatology\/41.2.196","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:42:52Z","timestamp":1027723372000},"page":"196-204","source":"Crossref","is-referenced-by-count":39,"title":["Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one\u2010year double\u2010blind study in 174 patients"],"prefix":"10.1093","volume":"41","author":[{"given":"R.","family":"Rau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Herborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Menninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Sangha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,2]]},"reference":[{"key":"key\n\t\t\t\t20170703120647_R1","doi-asserted-by":"crossref","unstructured":"Sharp JT. Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum1989;3:221\u20139.","DOI":"10.1002\/anr.1780320218"},{"key":"key\n\t\t\t\t20170703120647_R2","doi-asserted-by":"crossref","unstructured":"Felson DT, Anderson JJ, Boers M et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum1993;36:729\u201340.","DOI":"10.1002\/art.1780360601"},{"key":"key\n\t\t\t\t20170703120647_R3","doi-asserted-by":"crossref","unstructured":"Williams HJ, Willkens RF, Samuelson CO Jr et al. Comparison of low\u2010dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum1985;2:721\u201330.","DOI":"10.1002\/art.1780280702"},{"key":"key\n\t\t\t\t20170703120647_R4","doi-asserted-by":"crossref","unstructured":"Weinblatt ME, Coblyn JS, Fox DA et al. Efficacy of low\u2010dose methotrexate in rheumatoid arthritis. N Engl J Med1985;312:818\u201322.","DOI":"10.1056\/NEJM198503283121303"},{"key":"key\n\t\t\t\t20170703120647_R5","doi-asserted-by":"crossref","unstructured":"Andersen PA, West SG, O\u2019Dell JR, Via CS, Claypool RG, Kotzin BL. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomised, double\u2010blind study. Ann Intern Med1985;103:489\u201396.","DOI":"10.7326\/0003-4819-103-4-489"},{"key":"key\n\t\t\t\t20170703120647_R6","doi-asserted-by":"crossref","unstructured":"Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long\u2010term therapy for rheumatoid arthritis. Arthritis Rheum1986;29:822\u201331.","DOI":"10.1002\/art.1780290702"},{"key":"key\n\t\t\t\t20170703120647_R7","doi-asserted-by":"crossref","unstructured":"Kremer JM, Phelps CT. Long\u2010term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum1992;35:138\u201345.","DOI":"10.1002\/art.1780350203"},{"key":"key\n\t\t\t\t20170703120647_R8","doi-asserted-by":"crossref","unstructured":"Weinblatt ME, Trentham DE, Fraser PA et al. Long\u2010term prospective trial of low\u2010dose methotrexate in rheumatoid arthritis. Arthritis Rheum1988;31:167\u201375.","DOI":"10.1002\/art.1780310203"},{"key":"key\n\t\t\t\t20170703120647_R9","doi-asserted-by":"crossref","unstructured":"Weinblatt ME, Kaplan H, Germain BF et al. Methotrexate in rheumatoid arthritis. A five\u2010year prospective multicenter study. Arthritis Rheum1994;37:1492\u20138.","DOI":"10.1002\/art.1780371013"},{"key":"key\n\t\t\t\t20170703120647_R10","doi-asserted-by":"crossref","unstructured":"Weinblatt ME, Polisson R, Blotner SD et al. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36\u2010week randomised trial comparing methotrexate and auranofin. Arthritis Rheum1993;36:613\u20139.","DOI":"10.1002\/art.1780360507"},{"key":"key\n\t\t\t\t20170703120647_R11","unstructured":"Rau R, Schleusser B, Herborn G, Karger T. Longterm treatment of destructive rheumatoid arthritis with methotrexate. J Rheumatol1997;24:1881\u20139."},{"key":"key\n\t\t\t\t20170703120647_R12","doi-asserted-by":"crossref","unstructured":"Hanrahan PS, Scrivens GA, Russell AS. Prospective long term follow\u2010up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol1989;28:147\u201353.","DOI":"10.1093\/rheumatology\/28.2.147"},{"key":"key\n\t\t\t\t20170703120647_R13","unstructured":"Alarcon GS, Lopez\u2010Mendez A, Walter J et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta\u2010analysis. J Rheumatol1992;19:1868\u201373."},{"key":"key\n\t\t\t\t20170703120647_R14","doi-asserted-by":"crossref","unstructured":"Weinblatt ME, Weissman BN, Holdsworth DE et al. Long\u2010term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84\u2010month update. Arthritis Rheum1992;35:129\u201337.","DOI":"10.1002\/art.1780350202"},{"key":"key\n\t\t\t\t20170703120647_R15","doi-asserted-by":"crossref","unstructured":"Reykdal S, Steinsson K, Sigurjonsson K, Brekkan A. Methotrexate treatment of rheumatoid arthritis: effects on radiological progression. Scand J Rheumatol1989;18:221\u20136.","DOI":"10.3109\/03009748909099932"},{"key":"key\n\t\t\t\t20170703120647_R16","doi-asserted-by":"crossref","unstructured":"Rau R, Herborn G, Karger T, Werdier D. Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy. Arthritis Rheum1991;34:1236\u201344.","DOI":"10.1002\/art.1780341006"},{"key":"key\n\t\t\t\t20170703120647_R17","doi-asserted-by":"crossref","unstructured":"Jeurissen MEC, Boerbooms AMT, van de Putte LBA, Doesburg WH, Lemmens AM. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized double\u2010blind study. Ann Intern Med1991;114:999\u20131004.","DOI":"10.7326\/0003-4819-114-12-999"},{"key":"key\n\t\t\t\t20170703120647_R18","unstructured":"Maravic M, Bologna C, Daures J\u2010P et al. Radiologic progression in early rheumatoid arthritis treated with methotrexate. J Rheumatol1999;26:262\u20137."},{"key":"key\n\t\t\t\t20170703120647_R19","unstructured":"Rich E, Moreland LW, Alarcon GS. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug. J Rheumatol1999;26:259\u201361."},{"key":"key\n\t\t\t\t20170703120647_R20","doi-asserted-by":"crossref","unstructured":"Strand V, Cohen S, Schiff M et al. Treatment of active rheumatoid arthritis with Leflunomide compared with placebo and methotrexate. Arch Intern Med1999;159:2542\u201350.","DOI":"10.1001\/archinte.159.21.2542"},{"key":"key\n\t\t\t\t20170703120647_R21","doi-asserted-by":"crossref","unstructured":"Sharp JT, Strand V, Leung H et al. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum2000;43:495\u2013505.","DOI":"10.1002\/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U"},{"key":"key\n\t\t\t\t20170703120647_R22","doi-asserted-by":"crossref","unstructured":"Stenger AA, van Leeuwen MA, Houtman PM et al. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. Br J Rheumatol1998;37:1157\u201363.","DOI":"10.1093\/rheumatology\/37.11.1157"},{"key":"key\n\t\t\t\t20170703120647_R23","doi-asserted-by":"crossref","unstructured":"Empire Rheumatism Council. Gold therapy in rheumatoid arthritis: Final report of a multicentre controlled trial. Ann Rheum Dis1961;20:316\u201323.","DOI":"10.1136\/ard.20.4.315"},{"key":"key\n\t\t\t\t20170703120647_R24","doi-asserted-by":"crossref","unstructured":"Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR. Gold salts in the treatment of rheumatoid arthritis. A double\u2010blind study. Ann Intern Med1974;80:21\u20136.","DOI":"10.7326\/0003-4819-80-1-21"},{"key":"key\n\t\t\t\t20170703120647_R25","doi-asserted-by":"crossref","unstructured":"Cats A. A multicentre controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosage. Agents Actions1976;6:355\u201363.","DOI":"10.1007\/BF01972255"},{"key":"key\n\t\t\t\t20170703120647_R26","unstructured":"Wolfe F, Hawley DJ, Cathey MA. Measurement of gold treatment effect in clinical practice: Evidence for effectiveness of intramuscular gold therapy. J Rheumatol1993;20:797\u2013801."},{"key":"key\n\t\t\t\t20170703120647_R27","doi-asserted-by":"crossref","unstructured":"Anonymous. A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum1973;16:353\u20138.","DOI":"10.1002\/art.1780160309"},{"key":"key\n\t\t\t\t20170703120647_R28","doi-asserted-by":"crossref","unstructured":"Sharp JT, Lidsky MD, Duffy J. Clinical responses during gold therapy for rheumatoid arthritis. Changes in synovitis, radiologically detectable erosive lesions, serum proteins and serologic abnormalities. Arthritis Rheum1982;25:540\u20139.","DOI":"10.1002\/art.1780250508"},{"key":"key\n\t\t\t\t20170703120647_R29","unstructured":"Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14\u2010year prospective evaluation of 1017 consecutive starts. J Rheumatol1990;17:994\u20131002."},{"key":"key\n\t\t\t\t20170703120647_R30","unstructured":"Morassut P, Goldstein R, Cyr M, Karsh J, McKendry RJ. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis\u2014a randomised, double blind 26\u2010week trial. J Rheumatol1989;16:302\u20136."},{"key":"key\n\t\t\t\t20170703120647_R31","unstructured":"Rau R, Herborn G, Karger T, Menninger H, Elhardt D, Schmitt J. A double blind randomised parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. J Rheumatol1991;18:328\u201333."},{"key":"key\n\t\t\t\t20170703120647_R32","doi-asserted-by":"crossref","unstructured":"Sander O, Herborn G, Bock E, Rau R. Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate. Ann Rheum Dis1999;58:281\u20137.","DOI":"10.1136\/ard.58.5.281"},{"key":"key\n\t\t\t\t20170703120647_R33","doi-asserted-by":"crossref","unstructured":"Fries JF, Williams CA, Ramey D, Bloch DA. The relative toxicity of disease modifying antirheumatic drugs. Arthritis Rheum1993;36:297\u2013306.","DOI":"10.1002\/art.1780360303"},{"key":"key\n\t\t\t\t20170703120647_R34","unstructured":"Singh G, Fries JF, Williams CA, Zatarain E et al. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol1991;18:188\u201394."},{"key":"key\n\t\t\t\t20170703120647_R35","unstructured":"Suarez\u2010Almazor ME, Fitzgerald A, Grace M, Russell AS. A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis. J Rheumatol1988;15:753\u201366."},{"key":"key\n\t\t\t\t20170703120647_R36","doi-asserted-by":"crossref","unstructured":"Rau R, Herborn G, Menninger H, Sangha O. Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol1998;37:1220\u20136.","DOI":"10.1093\/rheumatology\/37.11.1220"},{"key":"key\n\t\t\t\t20170703120647_R37","doi-asserted-by":"crossref","unstructured":"Rau R, Herborn G, Menninger H et al. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double\u2010blind parallel study of 174 patients. Br J Rheumatol1997;36:345\u201352.","DOI":"10.1093\/rheumatology\/36.3.345"},{"key":"key\n\t\t\t\t20170703120647_R38","doi-asserted-by":"crossref","unstructured":"Menninger H, Herborn G, Sander O, Blechschmidt J, Rau R. A 36\u2010month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis. Br J Rheumatol1998;37:1060\u20138.","DOI":"10.1093\/rheumatology\/37.10.1060"},{"key":"key\n\t\t\t\t20170703120647_R39","unstructured":"Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis1958;9:175\u20136."},{"key":"key\n\t\t\t\t20170703120647_R40","unstructured":"Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A. A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol1998;25:2094\u2013107."},{"key":"key\n\t\t\t\t20170703120647_R41","doi-asserted-by":"crossref","unstructured":"M\u00f6tt\u00f6nen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis1988;47:648\u201353.","DOI":"10.1136\/ard.47.8.648"},{"key":"key\n\t\t\t\t20170703120647_R42","unstructured":"Matsuda Y, Yamanaka H, Higami K et al. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis. J Rheumatol1998;25:427\u201332."},{"key":"key\n\t\t\t\t20170703120647_R43","doi-asserted-by":"crossref","unstructured":"Landewe RB, Boonen E, van der Heijde DMFM et al. The disease activity score predicts radiological progression during the following 6 months of observation in a 5 year observational study: an example of advanced longitudinal data analysis. Ann Rheum Dis2001;60(Suppl. 1):124.","DOI":"10.1136\/annrheumdis-2001.1054"},{"key":"key\n\t\t\t\t20170703120647_R44","doi-asserted-by":"crossref","unstructured":"Jiang Y, Genant HK, Watt I et al. A multicenter, double\u2010blind, dose\u2010ranging, randomized, placebo\u2010controlled study of recombinant human interleukin\u20101 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum2000;43:1001\u20139.","DOI":"10.1002\/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P"},{"key":"key\n\t\t\t\t20170703120647_R45","doi-asserted-by":"crossref","unstructured":"Rau R, Wassenberg S, Zeidler H for the LDPT Study Group. Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis\u2014Preliminary results from a multicenter, randomised, parallel, double blind study. Z Rheumatol2000;59(Suppl. 2):90\u20136.","DOI":"10.1007\/s003930070026"},{"key":"key\n\t\t\t\t20170703120647_R46","unstructured":"Rau R, Wassenberg S, Zeidler H. Patterns of drug use in rheumatoid arthritis. J Rheumatol2001;28:1463\u20134."},{"key":"key\n\t\t\t\t20170703120647_R47","doi-asserted-by":"crossref","unstructured":"Bathon JM, Martin RW, Fleischmann RM et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med2000;343:1586\u201393.","DOI":"10.1056\/NEJM200011303432201"},{"key":"key\n\t\t\t\t20170703120647_R48","doi-asserted-by":"crossref","unstructured":"Amos RS, Constable TJ, Crockson RA, Crockson AP, McConkey B. Rheumatoid arthritis: relation of serum C\u2010reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J1977;1:195\u20137.","DOI":"10.1136\/bmj.1.6055.195"},{"key":"key\n\t\t\t\t20170703120647_R49","doi-asserted-by":"crossref","unstructured":"Fries JF, Bloch DA, Sharp JT et al. Assessment of radiologic progression in rheumatoid arthritis. A randomised, controlled trial. Arthritis Rheum1986;29:1\u20139.","DOI":"10.1002\/art.1780290101"},{"key":"key\n\t\t\t\t20170703120647_R50","doi-asserted-by":"crossref","unstructured":"Thompson PW, Silman AJ, Kirwan JR, Currey HL. Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute\u2010phase response. Arthritis Rheum1987;30:618\u201323.","DOI":"10.1002\/art.1780300603"},{"key":"key\n\t\t\t\t20170703120647_R51","doi-asserted-by":"crossref","unstructured":"Cats A, Hazevoet HM. Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow\u2010up study. Ann Rheum Dis1970;29:254\u201360.","DOI":"10.1136\/ard.29.3.254"},{"key":"key\n\t\t\t\t20170703120647_R52","doi-asserted-by":"crossref","unstructured":"Masi AT, Maldonado\u2010Cocco JA, Kaplan SB, Feigenbaum SL, Chandler RW. Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome. Semin Arthritis Rheum1976;4:299\u2013326.","DOI":"10.1016\/0049-0172(76)90013-5"},{"key":"key\n\t\t\t\t20170703120647_R53","doi-asserted-by":"crossref","unstructured":"Wawrzynska\u2010Pagowska J, Brzezinska B, Brzozowska M et al. Observations on the symptoms and signs of \u2018early\u2019 rheumatoid arthritis in a prospective study. Acta Rheumatol Scand1970;16:99\u2013105.","DOI":"10.3109\/rhe1.1970.16.issue-1-4.12"},{"key":"key\n\t\t\t\t20170703120647_R54","doi-asserted-by":"crossref","unstructured":"Arnason JA, Jonsson T, Brekkan A, Sigurjonsson K, Valdimarsson H. Relation between bone erosions and rheumatoid factor isotypes. Ann Rheum Dis1987;46:380\u20134.","DOI":"10.1136\/ard.46.5.380"},{"key":"key\n\t\t\t\t20170703120647_R55","doi-asserted-by":"crossref","unstructured":"Dawes PT, Fowler PD, Jackson R et al. Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D\u2010penicillamine therapy. Ann Rheum Dis1986;45:945\u20139.","DOI":"10.1136\/ard.45.11.945"},{"key":"key\n\t\t\t\t20170703120647_R56","doi-asserted-by":"crossref","unstructured":"Jacoby RK, Jayson MI, Cosh JA. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11\u2010year follow\u2010up. Br Med J1973;2:96\u2013100.","DOI":"10.1136\/bmj.2.5858.96"},{"key":"key\n\t\t\t\t20170703120647_R57","unstructured":"Tugwell P, Boers M. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. J Rheumatol1993;20:528\u201330."}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/41\/2\/196\/18095590\/410196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:51:47Z","timestamp":1621270307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/41.2.196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":57,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2002,2]]},"published-print":{"date-parts":[[2002,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/41.2.196","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}